Central to the new report (PDF) are the JEC Democrats' findings that Trump increased his stock holdings in the pharmaceutical ...

Medicus Pharma (NASDAQ:MDCX) priced its public offering of 2.26M units, on a "best-efforts" basis, at a price of $3.10 per unit. Each unit consists of one common share of the company and one warrant ...

OKYO Pharma Limited (OKYO) has announced a public offering of 10,815,000 ordinary shares priced at $1.85 each. The underwriter has a 30-day option to purchase an additional 1,622,250 shares at the ...

BridgeBio Pharma (BBIO) has priced its private offering of $550M aggregate principal amount of 0.75% convertible senior notes due 2033. In connection with the offering, the company granted the initial ...

Learn more BioMarin Pharmaceutical (BMRN) has an average rating of overweight and mean price target of $89.38, according to analysts polled by FactSet.

Pharma giants are navigating U.S. President Donald Trump's demands to bring U.S. drug prices in line with other developed nations. Eli Lilly's decision to hike Mounjaro prices in the U.K. could spark ...

President Donald Trump on Thursday demanded 17 pharmaceutical companies cut down their drug prices for American consumers, issuing a Sept. 29 deadline for the businesses to “end the free ride of ...

Ascendis Pharma A/S (ASND) has an average rating of buy and mean price target of $311.82, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research from ...

Nasus Pharma Ltd. (NYSE American: NSRX) priced its initial public offering of 1,250,000 ordinary shares at $8.00 per share, generating gross proceeds of $10 million before deducting underwriting fees ...

He blasted the European Union nation in particular over drug prices, alleging that the 27-nation bloc forced pharmaceutical firms to lower their costs on their ...

U.S. President Donald Trump signs an executive order on prescription drug prices, in the Roosevelt Room of the White House on May 12, 2025, in Washington, DC. Also pictured, L-R, Director of the ...